scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0065-3233(08)60487-8 |
P698 | PubMed publication ID | 8908296 |
P2093 | author name string | Eisen HN | |
Tsomides TJ | |||
Sykulev Y | |||
P2860 | cites work | ZAP-70: a 70 kd protein-tyrosine kinase that associates with the TCR zeta chain | Q24294340 |
Structure of the human class I histocompatibility antigen, HLA-A2 | Q24297966 | ||
A human T cell-specific cDNA clone encodes a protein having extensive homology to immunoglobulin chains | Q24301420 | ||
The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides | Q24339477 | ||
Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection | Q24561706 | ||
The CD4 receptor is complexed in detergent lysates to a protein-tyrosine kinase (pp58) from human T lymphocytes | Q24653345 | ||
A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas | Q24679739 | ||
The major histocompatibility complex-restricted antigen receptor on T cells. I. Isolation with a monoclonal antibody | Q24683570 | ||
Crystal structures of two viral peptides in complex with murine MHC class I H-2Kb | Q27642080 | ||
Crystal structure of the major histocompatibility complex class I H-2Kb molecule containing a single viral peptide: implications for peptide binding and T-cell receptor recognition | Q27642083 | ||
Different length peptides bind to HLA-Aw68 similarly at their ends but bulge out in the middle | Q27642184 | ||
Specificity pockets for the side chains of peptide antigens in HLA-Aw68 | Q27700642 | ||
The three-dimensional structure of H-2Db at 2.4 A resolution: implications for antigen-determinant selection | Q27729346 | ||
The antigenic identity of peptide-MHC complexes: A comparison of the conformations of five viral peptides presented by HLA-A2 | Q27729917 | ||
Crystal structure of the beta chain of a T cell antigen receptor | Q27729924 | ||
Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide | Q27731272 | ||
Bound water molecules and conformational stabilization help mediate an antigen-antibody association | Q27731557 | ||
Affinity maturation leads to differential expression of multiple copies of a κ light-chain transgene | Q60065187 | ||
Expression of two T cell receptor alpha chains: dual receptor T cells | Q61268447 | ||
Emerging principles for the recognition of peptide antigens by MHC class I molecules | Q67494475 | ||
Exact prediction of a natural T cell epitope | Q67702861 | ||
Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand | Q67903498 | ||
Antibody framework residues affecting the conformation of the hypervariable loops | Q68092016 | ||
Heterodimeric, disulfide-linked alpha/beta T cell receptors in solution | Q68291793 | ||
Why affinity progression of antibodies during immune responses is probably not accompanied by parallel changes in the immunoglobulin-like antigen-specific receptors on T cells | Q68810655 | ||
Three-dimensional structure of an antigen-antibody complex at 2.8 A resolution | Q68969863 | ||
Enhanced recognition of a modified peptide antigen by cytotoxic T cells specific for influenza nucleoprotein | Q69018238 | ||
Molecular mimicry and autoimmune disease | Q69205630 | ||
Selective induction of growth factor production and growth factor receptor expression by different signals to a single T cell | Q69377330 | ||
Antigen stimulation of cytolytic T lymphocyte precursors: minimal requirements for growth and acquisition of cytolytic activity | Q69872017 | ||
Evidence that a single peptide-MHC complex on a target cell can elicit a cytolytic T cell response | Q71169443 | ||
Partial T cell signaling: altered phospho-zeta and lack of zap70 recruitment in APL-induced T cell anergy | Q71988127 | ||
An autoantigenic T cell epitope forms unstable complexes with class II MHC: a novel route for escape from tolerance induction | Q72105874 | ||
T cell receptor-MHC class I peptide interactions: affinity, kinetics, and specificity | Q72112177 | ||
Allelic exclusion of alpha chains in TCRs | Q72189651 | ||
Antigenic peptide binding by class I and class II histocompatibility proteins | Q72192298 | ||
Kinetics and affinity of reactions between an antigen-specific T cell receptor and peptide-MHC complexes | Q72628246 | ||
TAP1-dependent peptide translocation in vitro is ATP dependent and peptide selective | Q72873502 | ||
Attachment of an anti-receptor antibody to non-target cells renders them susceptible to lysis by a clone of cytotoxic T lymphocytes | Q37580704 | ||
An optimal viral peptide recognized by CD8+ T cells binds very tightly to the restricting class I major histocompatibility complex protein on intact cells but not to the purified class I protein | Q37644137 | ||
Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes | Q37680808 | ||
Phospholipids enhance the binding of peptides to class II major histocompatibility molecules | Q37707645 | ||
Genetic and mutational analysis of the T-cell antigen receptor | Q37925514 | ||
Antibody-antigen complexes | Q37943232 | ||
T cell receptor gene diversity and selection | Q37943233 | ||
The basis for the immunoregulatory role of macrophages and other accessory cells | Q38174608 | ||
Antigen recognition by class I-restricted T lymphocytes | Q38201551 | ||
Acquisition of immunologic self-tolerance | Q38254157 | ||
Mapping T-cell receptor–peptide contacts by variant peptide immunization of single-chain transgenics | Q38330987 | ||
Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy | Q38624477 | ||
Implications of a Fab-like structure for the T-cell receptor | Q38666499 | ||
The role of the CD28 receptor during T cell responses to antigen | Q28263234 | ||
Presentation of viral antigen controlled by a gene in the major histocompatibility complex | Q28285937 | ||
Crystal structure of a soluble form of the human T cell coreceptor CD8 at 2.6 A resolution | Q28287140 | ||
Introduced T cell receptor variable region gene segments recombine in pre-B cells: evidence that B and T cells use a common recombinase | Q28298958 | ||
Sequence analysis of peptides bound to MHC class II molecules | Q28303686 | ||
Structure of the gene of tum- transplantation antigen P91A: the mutated exon encodes a peptide recognized with Ld by cytolytic T cells | Q28512984 | ||
T cell receptor antagonist peptides induce positive selection | Q29618820 | ||
T-cell antigen receptor genes and T-cell recognition | Q29619721 | ||
Signal transduction by lymphocyte antigen receptors | Q29619894 | ||
Atomic structure of a fragment of human CD4 containing two immunoglobulin-like domains | Q30195771 | ||
Peptides presented to the immune system by the murine class II major histocompatibility complex molecule I-Ad | Q30311282 | ||
Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry | Q30434686 | ||
HLA-A2.1-associated peptides from a mutant cell line: a second pathway of antigen presentation | Q30434689 | ||
Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines. | Q30463850 | ||
Association of the fyn protein-tyrosine kinase with the T-cell antigen receptor | Q33620349 | ||
The law of mass action governs antigen-stimulated cytolytic activity of CD8+ cytotoxic T lymphocytes | Q33637736 | ||
Cytotoxic T lymphocytes recognize a reconstituted class I histocompatibility antigen (HLA-A2) as an allogeneic target molecule | Q33676045 | ||
Structure of the T-cell antigen receptor: evidence for two CD3 epsilon subunits in the T-cell receptor-CD3 complex | Q33800570 | ||
Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein | Q34293468 | ||
Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. | Q34350288 | ||
HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides | Q34372218 | ||
Kinetic and affinity limits on antibodies produced during immune responses | Q34598643 | ||
Crystal structure of an HIV-binding recombinant fragment of human CD4. | Q34637157 | ||
Cell interactions between histoincompatible T and B lymphocytes. The H-2 gene complex determines successful physiologic lymphocyte interactions | Q34733830 | ||
T cells with two functional antigen-specific receptors | Q34756338 | ||
Induction of anti-tumor cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptide epitopes | Q35093159 | ||
Proteolysis, proteasomes and antigen presentation | Q35228583 | ||
Regulation of TCR alpha and beta gene allelic exclusion during T-cell development | Q35232298 | ||
A molecular model of MHC class-I-restricted antigen processing | Q35347353 | ||
Cell biology of antigen processing and presentation to major histocompatibility complex class I molecule-restricted T lymphocytes | Q35533657 | ||
Secondary, tertiary, and quaternary structure of T-cell-specific immunoglobulin-like polypeptide chains | Q35588811 | ||
CD8+ T lymphocytes of African green monkeys secrete an immunodeficiency virus-suppressing lymphokine | Q35621878 | ||
High-affinity reactions between antigen-specific T-cell receptors and peptides associated with allogeneic and syngeneic major histocompatibility complex class I proteins | Q35918289 | ||
Short-lived complexes between myelin basic protein peptides and IAk | Q35985828 | ||
Affinity and the immune response | Q47781047 | ||
Locus-specific somatic hypermutation in germinal centre T cells | Q48077130 | ||
Correlations between T-cell specificity and the structure of the antigen receptor | Q48365072 | ||
Complete primary structure of a heterodimeric T-cell receptor deduced from cDNA sequences. | Q48389926 | ||
Cell-mediated cytotoxicity to trinitrophenyl-modified syngeneic lymphocytes | Q48533870 | ||
Selective expression of an antigen receptor on CD8-bearing T lymphocytes in transgenic mice | Q50800754 | ||
Functional commitment to helper T cell lineage precedes positive selection and is independent of T cell receptor MHC specificity | Q51133242 | ||
Another view of the selective model of thymocyte selection | Q51142565 | ||
Positive and negative selection of an antigen receptor on T cells in transgenic mice | Q52249517 | ||
Identification of a CD4 binding site on the beta 2 domain of HLA-DR molecules | Q52443678 | ||
A pentapeptide as minimal antigenic determinant for MHC class I-restricted T lymphocytes | Q52538972 | ||
Cellular peptide composition governed by major histocompatibility complex class I molecules | Q53885926 | ||
Particle counting by flow cytometry can determine intrinsic equilibrium constants for antibody-ligand interactions in solution | Q54015447 | ||
Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules | Q55042699 | ||
Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system. | Q55061347 | ||
The mouse T cell receptor: structural heterogeneity of molecules of normal T cells defined by xenoantiserum | Q56872851 | ||
The major histocompatibility complex-restricted antigen receptor on T cells in mouse and man: Identification of constant and variable peptides | Q56889076 | ||
Real-time measurement of antigenic peptide binding to empty and preloaded single-chain major histocompatibility complex class I molecules | Q56941840 | ||
Isolation and characterization of antigen-la complexes involved in T cell recognition | Q57000170 | ||
CD8 modulation of T-cell antigen receptor–ligand interactions on living cytotoxic T lymphocytes | Q57040021 | ||
Molecular basis of antigen mimicry by an anti-idiotope | Q58670679 | ||
Specific antigen—la activation of transfected human T cells expressing murine Ti αβ —human T3 receptor complexes | Q58967140 | ||
Isolation of cDNA clones encoding T cell-specific membrane-associated proteins | Q59067678 | ||
Identification of self peptides bound to purified HLA-B27 | Q59068162 | ||
CTL induction by a tumour-associated antigen octapeptide derived from a murine lung carcinoma | Q59069991 | ||
Binding of immunogenic peptides to Ia histocompatibility molecules | Q59070314 | ||
Association of class I major histocompatibility heavy and light chains induced by viral peptides | Q59072754 | ||
A role for peptide in determining MHC class II structure | Q59077345 | ||
Peptides determine the lifespan of MHC class II molecules in the antigen-presenting cell | Q59077649 | ||
Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells | Q59078526 | ||
The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens | Q59092174 | ||
Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size | Q39229154 | ||
Predominant use of a V alpha gene segment in mouse T-cell receptors for cytochrome c. | Q39288171 | ||
Alpha beta lineage-specific expression of the alpha T cell receptor gene by nearby silencers | Q39521572 | ||
A hypothetical model of the foreign antigen binding site of class II histocompatibility molecules | Q39623507 | ||
Role of hydrophobicity in the binding of coenzymes. Appendix. Translational and rotational contribution to the free energy of dissociation | Q40176970 | ||
The human T-cell receptor | Q40216296 | ||
The B7 and CD28 receptor families | Q40392461 | ||
The ups and downs of T cell costimulation | Q40398747 | ||
Generation, translocation, and presentation of MHC class I-restricted peptides | Q40422033 | ||
Tumor antigens recognized by T lymphocytes | Q40661131 | ||
T-cell inhibition of humoral responsiveness. II. Theory on the role of restrictive recognition in immune regulation | Q40690063 | ||
Positive selection of lymphocytes | Q40807424 | ||
The biochemistry and cell biology of antigen processing and presentation | Q40898211 | ||
T cell antigen receptor signal transduction: a tale of tails and cytoplasmic protein-tyrosine kinases | Q40898871 | ||
Cross-reactivities in memory cytotoxic T lymphocyte recognition of heterologous viruses. | Q41030813 | ||
The outline structure of the T-cell alpha beta receptor. | Q41094902 | ||
T-cell-receptor affinity and thymocyte positive selection | Q41192128 | ||
Serial triggering of many T-cell receptors by a few peptide-MHC complexes | Q41346263 | ||
Zeta phosphorylation without ZAP-70 activation induced by TCR antagonists or partial agonists | Q41379043 | ||
Both high and low avidity antibodies to the T cell receptor can have agonist or antagonist activity | Q41440548 | ||
A cytotoxic T lymphocyte clone can recognize the same naturally occurring self peptide in association with a self and nonself class I MHC protein | Q41443366 | ||
MHC class II function preserved by low-affinity peptide interactions preceding stable binding | Q41447819 | ||
Peptide binding to the most frequent HLA-A class I alleles measured by quantitative molecular binding assays | Q41450491 | ||
Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells | Q41461980 | ||
Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants | Q41462011 | ||
Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes | Q41483867 | ||
A quantitative assay to measure the interaction between immunogenic peptides and purified class I major histocompatibility complex molecules | Q41489222 | ||
Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells | Q41532466 | ||
Antigen processing mutant T2 cells present viral antigen restricted through H-2Kb | Q41535379 | ||
Transporter-independent processing of HIV-1 envelope protein for recognition by CD8+ T cells | Q41542329 | ||
Stoichiometric labeling of peptides by iodination on tyrosyl or histidyl residues | Q41561181 | ||
Specific low-affinity recognition of major histocompatibility complex plus peptide by soluble T-cell receptor | Q41628039 | ||
The human class II MHC protein HLA-DR1 assembles as empty alpha beta heterodimers in the absence of antigenic peptide | Q41640226 | ||
The T cell receptor/CD3 complex is composed of at least two autonomous transduction modules. | Q41643996 | ||
Activation of T cells by a tyrosine kinase activation domain in the cytoplasmic tail of CD3 epsilon. | Q41644187 | ||
Low Affinity Interaction of Peptide-MHC Complexes with T Cell Receptors | Q41652382 | ||
On the nature of peptides involved in T cell alloreactivity | Q41657428 | ||
Peptide binding to class I MHC on living cells and quantitation of complexes required for CTL lysis | Q41675478 | ||
Restored expression of major histocompatibility class I molecules by gene transfer of a putative peptide transporter | Q41683715 | ||
Peptide selection by MHC class I molecules | Q41687117 | ||
The cytoplasmic domain of the T cell receptor zeta chain is sufficient to couple to receptor-associated signal transduction pathways | Q41691499 | ||
The role of beta 2-microglobulin in peptide binding by class I molecules | Q41710947 | ||
Isolation of an endogenously processed immunodominant viral peptide from the class I H–2Kb molecule | Q41714857 | ||
The minimal number of class II MHC-antigen complexes needed for T cell activation | Q41724410 | ||
Direct binding of peptide to empty MHC class I molecules on intact cells and in vitro. | Q41725161 | ||
Quantitation of antigen-presenting cell MHC class II/peptide complexes necessary for T-cell stimulation | Q41725217 | ||
Empty MHC class I molecules come out in the cold | Q41725383 | ||
The biosynthetic pathway of MHC class II but not class I molecules intersects the endocytic route | Q41737562 | ||
Limit of T cell tolerance to self proteins by peptide presentation | Q41739980 | ||
The kinetics of antibody binding to membrane antigens in solution and at the cell surface | Q41982863 | ||
Kinetic maturation of an immune response | Q42018143 | ||
Identification of naturally processed viral nonapeptides allows their quantification in infected cells and suggests an allele-specific T cell epitope forecast | Q42087769 | ||
Clonotypic structures involved in antigen-specific human T cell function. Relationship to the T3 molecular complex | Q42936415 | ||
A kinetic intermediate in the reaction of an antigenic peptide and I-Ek | Q43440073 | ||
A third rearranged and expressed gene in a clone of cytotoxic T lymphocytes | Q44462817 | ||
Characterization of Naturally Occurring Minor Histocompatibility Peptides Including H-4 and H-Y | Q44514515 | ||
The binding affinity and dissociation rates of peptides for class I major histocompatibility complex molecules | Q44625079 | ||
Transfer of specificity by murine alpha and beta T-cell receptor genes | Q44774041 | ||
Autologous peptides constitutively occupy the antigen binding site on Ia. | Q44907850 | ||
Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T cells | Q45007765 | ||
Evidence for a differential avidity model of T cell selection in the thymus | Q45155438 | ||
Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor | Q45986774 | ||
A locus control region in the T cell receptor alpha/delta locus | Q46057798 | ||
A TCR binds to antagonist ligands with lower affinities and faster dissociation rates than to agonists | Q46121537 | ||
Peptide-dependent recognition of H-2Kb by alloreactive cytotoxic T lymphocytes | Q46197161 | ||
Effects of peptide length and composition on binding to an empty class I MHC heterodimer | Q46340241 | ||
Direct binding of influenza peptides to class I HLA molecules | Q46490144 | ||
Characterization of a naturally processed MHC class II-restricted T-cell determinant of hen egg lysozyme | Q46739108 | ||
Evidence for a stochastic mechanism in the differentiation of mature subsets of T lymphocytes. | Q46778527 | ||
Kinetics of T-cell receptor binding to peptide/I-Ek complexes: correlation of the dissociation rate with T-cell responsiveness | Q36009049 | ||
Endogenously synthesized peptide with an endoplasmic reticulum signal sequence sensitizes antigen processing mutant cells to class I-restricted cell-mediated lysis | Q36230273 | ||
Allelic exclusion at DNA rearrangement level is required to prevent coexpression of two distinct T cell receptor beta genes | Q36230452 | ||
Endogenous peptides of a soluble major histocompatibility complex class I molecule, H-2Lds: sequence motif, quantitative binding, and molecular modeling of the complex | Q36232156 | ||
Immunoprecipitation of cell surface structures of cloned cytotoxic T lymphocytes by clone-specific antisera | Q36247967 | ||
Function of macrophages in antigen recognition by guinea pig T lymphocytes. I. Requirement for histocompatible macrophages and lymphocytes | Q36272607 | ||
The strange cross-reaction of menadione (vitamin K3) and 2,4-dinitrophenyl ligands with a myeloma protein and some conventional antibodies | Q36273220 | ||
Histocompatibility antigen-activated cytotoxic T lymphocytes. II. Estimates of the frequency and specificity of precursors | Q36335542 | ||
Antigen-inducible, H-2-restricted, interleukin-2-producing T cell hybridomas. Lack of independent antigen and H-2 recognition | Q36344766 | ||
A clone-specific monoclonal antibody that inhibits cytolysis of a cytolytic T cell clone | Q36347595 | ||
In vitro cell-mediated immune responses to the male specific(H-Y) antigen in mice | Q36358603 | ||
The major histocompatibility complex determines susceptibility to cytotoxic T cells directed against minor histocompatibility antigens | Q36358831 | ||
High frequency of cross-reactive cytotoxic T lymphocytes elicited during the virus-induced polyclonal cytotoxic T lymphocyte response | Q36361251 | ||
Peptide-major histocompatibility complex class II complexes with mixed agonist/antagonist properties provide evidence for ligand-related differences in T cell receptor-dependent intracellular signaling | Q36361605 | ||
Clone-specific T cell receptor antagonists of major histocompatibility complex class I-restricted cytotoxic T cells | Q36361774 | ||
Expression of two alpha chains on the surface of T cells in T cell receptor transgenic mice | Q36362577 | ||
Peptide length and sequence specificity of the mouse TAP1/TAP2 translocator | Q36362717 | ||
Amino acid residues that flank core peptide epitopes and the extracellular domains of CD4 modulate differential signaling through the T cell receptor | Q36363264 | ||
Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes | Q36363449 | ||
Stoichiometry of the T cell antigen receptor (TCR) complex: each TCR/CD3 complex contains one TCR alpha, one TCR beta, and two CD3 epsilon chains | Q36363495 | ||
Naturally processed viral peptides recognized by cytotoxic T lymphocytes on cells chronically infected by human immunodeficiency virus type 1 | Q36363763 | ||
Mass spectrometric identification of a naturally processed melanoma peptide recognized by CD8+ cytotoxic T lymphocytes | Q36364266 | ||
A third type of murine T-cell receptor gene | Q36613724 | ||
A ubiquitous protein is the source of naturally occurring peptides that are recognized by a CD8+ T-cell clone | Q36699072 | ||
Solution binding of an antigenic peptide to a major histocompatibility complex class I molecule and the role of beta 2-microglobulin | Q36890441 | ||
Kinetics of protein-protein association explained by Brownian dynamics computer simulation | Q36949476 | ||
Quantitation of reversible binding by particle counting: hapten-antibody interaction as a model system | Q37024416 | ||
Identification of the naturally processed form of hen egg white lysozyme bound to the murine major histocompatibility complex class II molecule I-Ak | Q37147375 | ||
Crawling movements of lymphocytes on and beneath fibroblasts in culture | Q37334000 | ||
Interactions between immunogenic peptides and MHC proteins | Q37357891 | ||
Precise prediction of a dominant class I MHC-restricted epitope of Listeria monocytogenes | Q37436836 | ||
Kinetics of antigenic peptide binding to the class II major histocompatibility molecule I-Ad | Q37519795 | ||
Alloreactive T cells discriminate among a diverse set of endogenous peptides | Q37530676 | ||
P304 | page(s) | 1-56 | |
P577 | publication date | 1996-01-01 | |
P13046 | publication type of scholarly work | review article | Q7318358 |
P1433 | published in | Advances in Protein Chemistry | Q15756442 |
P1476 | title | Antigen-specific T-cell receptors and their reactions with complexes formed by peptides with major histocompatibility complex proteins | |
P478 | volume | 49 |
Q35101815 | A model T-cell receptor system for studying memory T-cell development |
Q47733735 | A mutant human β2-microglobulin can be used to generate diverse multimeric class I peptide complexes as specific probes for T cell receptors |
Q74545050 | Alanine Scanning Mutagenesis of an αβ T Cell Receptor: Mapping the Energy of Antigen Recognition |
Q33731073 | Alphabeta T cell receptor interactions with syngeneic and allogeneic ligands: affinity measurements and crystallization |
Q33720544 | Binding energetics of T-cell receptors: correlation with immunological consequences |
Q40628580 | Broadly Increased Sensitivity to Cytotoxic T Lymphocytes Resulting from Nef Epitope Escape Mutations |
Q41574270 | Characteristics of the intrahepatic cytotoxic T lymphocyte response in chronic hepatitis C virus infection |
Q40663321 | Chimeric immune receptor T cells bypass class I requirements and recognize multiple cell types relevant in HIV-1 infection |
Q40151758 | Critical biological parameters modulate affinity as a determinant of function in T-cell receptor gene-modified T-cells |
Q27639247 | Crystal structure of a non-canonical low-affinity peptide complexed with MHC class I: a new approach for vaccine design |
Q27639768 | Crystal structure of an MHC class I presented glycopeptide that generates carbohydrate-specific CTL |
Q37308343 | Cutting edge: TLR ligands increase TCR triggering by slowing peptide-MHC class I decay rates |
Q36370382 | Determinant of HIV-1 mutational escape from cytotoxic T lymphocytes |
Q34478717 | Development of CD4+ T cells expressing a nominally MHC class I-restricted T cell receptor by two different mechanisms. |
Q34099738 | Differences in antigen recognition and cytolytic activity of CD8(+) and CD8(-) T cells that express the same antigen-specific receptor |
Q39654323 | Early T-cell activation biophysics. |
Q36367702 | Effects of complementarity determining region mutations on the affinity of an alpha/beta T cell receptor: measuring the energy associated with CD4/CD8 repertoire skewing |
Q44255903 | Efficient T cell activation requires an optimal dwell-time of interaction between the TCR and the pMHC complex |
Q74286685 | Functional avidity maturation of CD8(+) T cells without selection of higher affinity TCR |
Q34056465 | Immunopathogenesis of HIV-1 infection |
Q30861962 | In vitro evolution of a T cell receptor with high affinity for peptide/MHC. |
Q36380627 | Initiation Codon Scanthrough versus Termination Codon Readthrough Demonstrates Strong Potential for Major Histocompatibility Complex Class I–restricted Cryptic Epitope Expression |
Q38093572 | Modulation of tumor immunity by soluble and membrane-bound molecules at the immunological synapse. |
Q39682548 | Nef-mediated resistance of human immunodeficiency virus type 1 to antiviral cytotoxic T lymphocytes |
Q40996486 | Peptide antagonism and T cell receptor interactions with peptide-MHC complexes |
Q47817942 | Quantitative aspects of T-cell recognition: from within the antigen-presenting cell to within the T cell |
Q36368381 | Role of 2CT cell receptor residues in the binding of self- and allo-major histocompatibility complexes |
Q35691052 | Stage-dependent reactivity of thymocytes to self-peptide--MHC complexes |
Q33655849 | Strategies to genetically engineer T cells for cancer immunotherapy |
Q27758459 | Structural basis of 2C TCR allorecognition of H-2Ld peptide complexes |
Q77158682 | Structural principles that govern the peptide-binding motifs of class I MHC molecules |
Q37823023 | T Cell Receptor Signaling Kinetics Takes the Stage |
Q33935247 | T cell receptor binding kinetics required for T cell activation depend on the density of cognate ligand on the antigen-presenting cell. |
Q30873107 | TCRs with high affinity for foreign pMHC show self-reactivity |
Q34956078 | The T-cell response in patients with cancer |
Q33351448 | The effect of mutations on the alloreactive T cell receptor/peptide-MHC interface structure: a molecular dynamics study |
Q33737674 | The impact of TCR-binding properties and antigen presentation format on T cell responsiveness |
Q35941639 | The regulation and maturation of antiviral immune responses |
Q40895891 | The role of peptides in T cell alloreactivity is determined by self-major histocompatibility complex molecules |
Search more.